M. Arkin (1999) Ltd.

M. Arkin (1999) Ltd., also known as Arkin Holdings, is a prominent Israeli private investment firm founded by Mori Arkin in 2009. The firm focuses on investments in the life sciences and healthcare sectors, including pharmaceuticals, biotechnology, and medical devices. Arkin Holdings manages a diverse portfolio of companies, ranging from early-stage startups to established enterprises, with a particular emphasis on innovative therapies and medical technologies.

The firm's investment strategy encompasses various stages of company development, from early-stage ventures to pre-IPO opportunities. Arkin Holdings has demonstrated a commitment to supporting groundbreaking therapies in areas of high unmet medical need, as evidenced by its partnership in Arkin Bio-Ventures II, a fund dedicated to investing in private companies developing novel treatments. This initiative reflects the firm's dedication to advancing healthcare through strategic investments.

Arkin Holdings' track record includes significant investments in companies such as Sol-Gel Technologies, a dermatology-focused firm, and Urogen Pharma, a urology-focused biopharmaceutical company. The firm's founder, Mori Arkin, has a longstanding history in the pharmaceutical industry, having previously led Agis Industries, which was acquired by Perrigo in 2005. His extensive experience and strategic vision continue to guide Arkin Holdings in its mission to foster innovation and growth within the life sciences sector.